Louise Rodino-Klapac - Insider Trading & Ownership

Location
215 First Street, Ste 415, Cambridge, MA
Summary
The estimated net worth of Louise Rodino-Klapac is at least $6.64M dollars as of September 5, 2025. Louise Rodino-Klapac is the President, R&D and Tech Ops of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $6.64M.
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Louise Rodino-Klapac
All Insider Reports
All Insider Reports

Ownership of Louise Rodino-Klapac

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRPT Sarepta Therapeutics, Inc. President, R&D and Tech Ops $6.64M Sep 3, 2025

Insider Transactions Reported by Louise Rodino-Klapac:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.